Enveric BiosciencesENVB
13F holders, Q1 2025 (March 31)15holders
1famous investor
$1.36avg. 13F price*
At the end of Q1 2025, 15 institutions reported holding Enveric Biosciences Inc. (ENVB) in their 13F filings. The largest holders were AdvisorShares Investments LLC ($118K), UBS Group AG ($59K) and HRT Financial LP ($56K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Enveric Biosciences Inc.
- CUSIP
- 29405E406
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 15 | $345K |
| Exits | 0 | $0 |
Ownership 15 holders
| AdvisorShares Investments LLC | 0.02% | New | 90,324 | $118K |
| UBS Group AG | 0.00% | New | 42,760 | $59K |
| HRT Financial LP | 0.00% | New | 40,625 | $56K |
| Geode Capital Management, LLC | 0.00% | New | 26,558 | $37K |
| Virtu Financial LLC | 0.00% | New | 25,622 | $36K |
| Citadel Advisors | 0.00% | New | 20,060 | $28K |
| FMR LLC | 0.00% | New | 3,426 | $5K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 2,372 | $3K |
| SBI Securities Co., Ltd. | 0.00% | New | 725 | $1K |
| BlackRock, Inc. | 0.00% | New | 601 | $835 |
| Headlands Technologies LLC | 0.00% | New | 110 | $153 |
| Barclays PLC | 0.00% | New | 30 | $42 |
| Group One Trading LLC | 0.00% | New | 19 | $26 |
| National Bank of Canada | 0.00% | New | 5 | $7 |
| Wells Fargo & Company | 0.00% | New | 2 | $3 |
"% of holder's portfolio" is ENVB's weight in each manager's 13F, not the share of Enveric Biosciences Inc. the manager owns.